Sialorrhea

Sialorrhea is the indication for 2 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as: Sialorrhea (Excessive Drooling)
Classified under: Digestive System Diseases
Nervous System Diseases
Signs, Symptoms, and General Pathologies
Indicated drugs: Botulinum toxin type A
Glycopyrronium

Resolves to

Vocabularies

MeSHM0019820ICD-10K11.7SNOMED CT139278009MedDRA10020746UMLSC0037036

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

32Clinical trialsPhase, status and sponsor resolved per trial

4Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Sialorrhea share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.